antibody-drug-conjugate

Jul 18, 2026

• entity
• egfr
• her-family
• antibody-drug-conjugate

Jul 18, 2026

• antibody-drug-conjugate
• entity

Jul 18, 2026

• official-account
• breast-cancer
• metastatic-breast-cancer
• antibody-drug-conjugate
• maintenance-therapy

Jul 18, 2026

• official-account
• antibody-drug-conjugate
• bioorthogonal-chemistry
• tumor-heterogeneity
• preclinical

Jul 18, 2026

• antibody-drug-conjugate
• resistance
• concept

Jul 18, 2026

• concept
• her2
• spatial-heterogeneity
• antibody-drug-conjugate

Jul 17, 2026

• official-account
• breast-cancer
• t-dxd
• antibody-drug-conjugate
• drug-resistance

Jul 17, 2026

• group-study
• presentation
• breast-cancer
• antibody-drug-conjugate

Jul 17, 2026

• group-study
• breast-cancer
• antibody-drug-conjugate

Jul 15, 2026

• group-study
• her2-positive-tumor
• antibody-drug-conjugate
• drug-resistance

Jul 15, 2026

• group-study
• triple-negative-breast-cancer
• clinical-trial
• antibody-drug-conjugate

Jul 15, 2026

• antibody-drug-conjugate
• sequencing
• concept